PALB2

San Francisco, California, and Hong Kong, China, September 9, 2026 1cBio and Lee’s Pharmaceutical Holdings Limited (Lee’s Pharm) have...

TAIPEI, Taiwan — August 25, 2026 Senhwa Biosciences announced that it has completed patient enrollment in its Phase 1b...